Radiation-guided targeting of combretastatin encapsulated immunoliposomes to mammary tumors

Pharmaceutical Research

Volumn 26, Issue 5, 2009, Pages 1093-1100

  Pattillo, Christopher B ^a   Venegas, Berenice ^b   Donelson, Fred J ^a   Del Valle, Luis ^b   Knight, Linda C ^b   Chong, Parkson L G ^b   Kiani, Mohammad F ^a,b  

^a Temple University   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion molecules; Combretastatin; Immunoliposomes; Targeted drug delivery; Tumor vasculature targeting

Indexed keywords

CELL ADHESION MOLECULE; COMBRETASTATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOLIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DRUG FORMULATION; DRUG TARGETING; ENCAPSULATION; ENDOTHELIUM CELL; FEMALE; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE FRACTIONATION; SINGLE DRUG DOSE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIBENZYLS; BREAST NEOPLASMS; DRUG DELIVERY SYSTEMS; E-SELECTIN; FEMALE; LIPOSOMES; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; RADIATION; UP-REGULATION;

EID: 63949085116     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9826-1     Document Type: Article

References (25)

1. P. E. Thorpe 2004 Vascular targeting agents as cancer therapeutics Clin. Cancer Res. 10 415 427 doi:10.1158/1078-0432.CCR-0642-03
2. R. Murata J. Overgaard M. R. Horsman 2001 Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues Int. J. Radiat. Biol. 77 195 204 doi:10.1080/09553000010007695
3. D. J. Chaplin G. R. Pettit S. A. Hill 1999 Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate Anticancer Res. 19 189 195
4. K. Grosios S. E. Holwell A. T. McGown G. R. Pettit M. C. Bibby 1999 In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug Br. J. Cancer 81 1318 1327 doi:10.1038/sj.bjc.6692174
5. A. Gabizon H. Shmeeda Y. Barenholz 2003 Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies Clin. Pharmacokinet. 42 419 436 doi:10.2165/00003088-200342050-00002
6. R. M. Schiffelers G. A. Koning T. L. ten Hagen M. H. Fens A. J. Schraa A. P. Janssen R. J. Kok G. Molema G. Storm 2003 Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Control. Release 91 115 122 doi:10.1016/S0168-3659(03)00240-2
7. W. Landuyt B. Ahmed S. Nuyts J. Theys M. O. P. de Beeck A. Rijnders J. Anne A. van Oosterom B. W. van den P. Lambin 2001 In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment Int. J. Radiat. Oncol. Biol. Phys. 49 443 450 doi:10.1016/S0360- 3016(00)01470-X
8. W. R. Wilson A. E. Li D. S. M. Cowan B. G. Siim 1998 Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid Int. J. Radiat. Oncol. Biol. Phys. 42 905 908 doi:10.1016/S0360-3016(98) 00358-7
9. M. F. Kiani H. Yuan X. Chen L. Smith M. W. Gaber D. J. Goetz 2002 Targeting microparticles to select tissue via radiation-induced upregulation of endothelial cell adhesion molecules Pharm. Res. 19 1317 1322 doi:10.1023/A:1020350708672
10. C. B. Pattillo F. Sari-Sarraf R. Nallamothu B. M. Moore G. C. Wood M. F. Kiani 2005 Targeting of the antivascular drug combretastatin to irradiated tumors results in tumor growth delay Pharm. Res. 22 1117 1120 doi:10.1007/s11095-005-5646-0
11. D. R. Stacy B. Lu D. E. Hallahan 2004 Radiation-guided drug delivery systems Expert Rev. Anticancer Ther. 4 283 288 doi:10.1586/14737140.4.2.283
12. H. Yuan D. J. Goetz M. W. Gaber A. C. Issekutz T. E. Merchant M. F. Kiani 2005 Radiation-induced up-regulation of adhesion molecules in brain microvasculature and their modulation by dexamethasone Radiat. Res. 163 544 551 doi:10.1667/RR3361
13. G. R. Pettit S. B. Singh M. R. Boyd E. Hamel R. K. Pettit J. M. Schmidt F. Hogan 1995 Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a) J. Med. Chem. 38 1666 1672 doi:10.1021/jm00010a011
14. H. Leontiadou A. E. Mark S. J. Marrink 2004 Molecular dynamics simulations of hydrophilic pores in lipid bilayers Biophys. J. 86 2156 2164
15. G. R. Bartlett 1959 Phosphorus assay in column chromatography J. Biol. Chem. 234 466 468
16. C. B. Pattillo. Liposomal targeting of the antivascular drug combretastatin to irradiated tumors. Ph. D. Dissertation, Temple University 2007.
17. B. M. Fenton S. F. Paoni J. Lee C. J. Koch E. M. Lord 1999 Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements Br. J. Cancer 79 464 471 doi:10.1038/sj.bjc.6690072
18. S. L. Young D. J. Chaplin 2004 Combretastatin A4 phosphate: background and current clinical status Expert Opin. Investig. Drugs 13 1171 1182 doi:10.1517/13543784.13.9.1171
19. J. H. Bilenker K. T. Flaherty M. Rosen L. Davis M. Gallagher J. P. Stevenson W. Sun D. Vaughn B. Giantonio R. Zimmer M. Schnall P. J. O'Dwyer 2005 Phase I trial of combretastatin a-4 phosphate with carboplatin Clin. Cancer Res. 11 1527 1533 doi:10.1158/1078-0432.CCR-04-1434
20. J. P. Stevenson M. Rosen W. Sun M. Gallagher D. G. Haller D. Vaughn B. Giantonio R. Zimmer W. P. Petros M. Stratford D. Chaplin S. L. Young M. Schnall P. J. O'Dwyer 2003 Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow J. Clin. Oncol. 21 4428 4438 doi:10.1200/JCO.2003.12.986
21. G. J. Rustin S. M. Galbraith H. Anderson M. Stratford L. K. Folkes L. Sena L. Gumbrell P. M. Price 2003 Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results J. Clin. Oncol. 21 2815 2822 doi:10.1200/JCO.2003.05.185
22. A. Dowlati K. Robertson M. Cooney W. P. Petros M. Stratford J. Jesberger N. Rafie B. Overmoyer V. Makkar B. Stambler A. Taylor J. Waas J. S. Lewin K. R. McCrae S. C. Remick 2002 A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer Cancer Res. 62 3408 3416
23. R. Nallamothu G. C. Wood C. B. Pattillo R. C. Scott M. F. Kiani B. M. Moore L. A. Thoma 2006 A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation AAPS PharmSciTech. 7 E32 doi:10.1208/pt070232
24. J. M. Brown 2007 Tumor hypoxia in cancer therapy Methods Enzymol. 435 297 321
25. R. Nallamothu G. C. Wood M. F. Kiani B. M. Moore F. P. Horton L. A. Thoma 2006 A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies PDA J. Pharm. Sci. Technol. 60 144 155